July 2026: Inaugural Helen Thomas Early Career Fellowship in Type 1 Diabetes Announced
ADS/Breakthrough T1D/Diabetes Victoria/SVI Helen Thomas Early Career Fellowship in Type 1 Diabetes In recognition of her significant contributions to type 1 diabetes research, the Australian Diabetes Society (ADS), Breakthrough T1D […]
May 2026: Government Response to the Parliamentary Inquiry into Diabetes
‘Significant step forward’: Diabetes health and research leaders welcome government response to landmark inquiry The Australian Diabetes Society (ADS and its divisions NADC and DFA), Australian Diabetes Educators Association (ADEA), […]
November 2025: Launch of the National Diabetes Research Strategy 2026-2035
Official Launch of the National Diabetes Research Strategy for 2026-2035 In recognition of World Diabetes Day 2025, the Australian Diabetes Society is proud to announce the official launch of the […]
September 2025: Updated ADS MAFLD Living Clinical Guideline & Updated Australian Obesity Management Algorithm
Updated ADS Living Clinical Guideline on MAFLD in People with Diabetes The Australian Diabetes Society (ADS) has made important updates to the ADS MAFLD living clinical guideline with respect to […]
August 2025: National Diabetes Research Strategy (2026-2035) & Updated Australian Obesity Management Algorithm
National Diabetes Research Strategy for 2026-2035 A comprehensive strategy to drive impactful, equitable and sustainable diabetes research and improved diabetes care for the benefit of all Australians. The National Diabetes […]
July 2025: Australian Strategy for Foot Health and Disease in Diabetes 2030
New diabetes-related foot disease (DFD) national strategy The Australian Diabetes Society and Diabetes Feet Australia are committed to improving the foot health outcomes for people living with diabetes and in […]
Updated clinical practice recommendations regarding the periprocedural use of GLP-1RAs and GLP-1/GIPRAs (April 2025)
Based on new evidence from clinical studies and to make recommendations clearer, clinical practice recommendations for patients taking GLP-1 RA and dual GLP-1/GIP RAs prior to anaesthesia or sedation have […]
August 2024: New ADS Guideline and Consensus Statement
Joint ADS/ANZSNM guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (August 2024) A joint guideline by the Australian Diabetes Society (ADS) and Australian and […]
Updated Australian Obesity Management Algorithm
Revised Australian Obesity Management Algorithm The Australian Diabetes Society (ADS) has updated the Australian Obesity Management Algorithm position statement. Download the updated Australian Obesity Management Algorithm Position Statement (July 2024) […]
Clinical Practice Recommendation On Periprocedural Use Of GLP-1/GIP Receptor Agonists (June 2024)
A consensus clinical practice recommendation endorsed by the Australian Diabetes Society (ADS), National Association of Clinical Obesity Services (NACOS), Gastroenterological Society of Australia (GESA) and Australian and New Zealand College […]